FGFR2-positive circulating tumor cells were significantly correlated with FGFR2 overexpression and gene amplification in the surgical specimen of a gastric tumor, which validates a potential liquid-biopsy-based approach towards screening and monitoring for FGFR2-amplified gastric cancer [28]. The gene discussed is FGFR2; the disease is gastric neoplasm.